Use of dupilumab in bullous pemphigoid: where are we now?

HIGHLIGHTS

  • who: Roberto Russo and collaborators from the Department of Health Science (DISSAL), University of Genoa, Genoa, Italy have published the research: Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?, in the Journal: (JOURNAL)
  • what: The authors report the results of a literature review on the use of dupilumab in BP including a total of 30 treated patients in 9 papers.

SUMMARY

    The first case report actually dates back to 2018: a patient with BP refractory to prednisone was successfully treated with dupilumab. Later, Seidman et_al as well as Saleh . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?